Overview

Cholinergic Anti-inflammatory Pathway in Prevention & Treatment of the SIRS in Patients With Jaundice After Operation.

Status:
Unknown status

Trial end date:
2017-09-01

Target enrollment:

Participant gender:

Summary

RATIONALE:Anticholinesterase drugs and cholinergic M receptor antagonist are applied to patients who have obstructive jaundice after operation. PURPOSE:This clinical trial was designed to lower the incidence and mortality of operation complications in patients with obstructive jaundice .

Phase:

Phase 1/Phase 2

Details

Lead Sponsor:

Wanqing Gu

Treatments:

Anti-Inflammatory Agents
Neostigmine